|1.||Wang, Li: 3 articles (08/2011 - 06/2008)|
|2.||Yamagata, Tatsuya: 3 articles (08/2011 - 06/2008)|
|3.||Yamagata, Sadako: 3 articles (08/2011 - 06/2008)|
|4.||Sato, Toshinori: 3 articles (08/2011 - 06/2008)|
|5.||Zhang, Lan: 2 articles (08/2011 - 08/2010)|
|6.||Cao, Ting: 2 articles (08/2011 - 08/2010)|
|7.||Wang, Yinan: 2 articles (08/2011 - 06/2008)|
|8.||Wang, Yiren: 1 article (09/2015)|
|9.||Cao, Fayang: 1 article (09/2015)|
|10.||Cui, Yuting: 1 article (09/2015)|
|2.||Osteosarcoma (Osteogenic Sarcoma)
08/01/2011 - "Ganglioside GD1a suppresses metastatic capacity in murine FBJ osteosarcoma cells and MET phosphorylation activated by HGF binding, but the signaling pathway controlling HGF production has not been fully explored. "
08/01/2010 - "Murine FBJ osteosarcoma-derived FBJ-S1 cells are poorly metastatic and express the ganglioside GD1a, whereas highly metastatic FBJ-LL cells only slightly express this ganglioside. "
08/01/2010 - "Ganglioside GD1a suppression of NOS2 expression via ERK1 pathway in mouse osteosarcoma FBJ cells."
06/27/2008 - "Ganglioside GD1a suppresses TNFalpha expression via Pkn1 at the transcriptional level in mouse osteosarcoma-derived FBJ cells."
08/01/2011 - "Ganglioside GD1a negatively regulates hepatocyte growth factor expression through caveolin-1 at the transcriptional level in murine osteosarcoma cells."
01/01/1988 - "In addition, ganglioside GD1 alpha was detected in the solid tumors. "
11/01/2001 - "We previously reported that ganglioside GD1a, which is highly expressed in poorly metastatic FBJ-S1 cells, inhibits the serum-induced motility of FBJ-LL cells and that the metastatic potential of FBJ-LL cells is completely suppressed by enforced GD1a expression (Hyuga et al., Int J Cancer 1999;83:685-91). "
11/01/2001 - "Ganglioside GD1a inhibits HGF-induced motility and scattering of cancer cells through suppression of tyrosine phosphorylation of c-Met."
|4.||Myeloid Leukemia (Leukemia, Myelocytic)
02/01/1988 - "Appearance of a novel type of ganglioside (GD1 alpha) in a differentiation-resistant clone of mouse myeloid leukemia cells, M1-R1."
07/25/1995 - "Interleukin-3-associated expression of gangliosides in mouse myelogenous leukemia NFS60 cells introduced with interleukin-3 gene: expression of ganglioside GD1a and key involvement of CMP-NeuAc:lactosylceramide alpha 2-->3-sialyltransferase in GD1a expression."
11/01/2004 - "Unsupplemented C6 cells show a low basal level of infection but become highly infectable by Py following preincubation with the sialic acid-containing ganglioside GD1a (38). "
04/01/2011 - "Lentiviral infection of hMSCs successfully induced a marked inhibition of ST3Gal II mRNA expression and caused a significant decrease in ALP activity and ganglioside GD1a expression. "
|3.||Toll-Like Receptor 4
|4.||N-Acetylneuraminic Acid (Sialic Acid)
|5.||Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
|6.||Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
|8.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|9.||Tretinoin (Retinoic Acid)
|10.||Messenger RNA (mRNA)